Research progress in drug therapy for coronavirus disease 2019
Author:
Affiliation:

Clc Number:

R563.1

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Comments
    Abstract:

    Effective antiviral therapy and vaccine preventive measure for coronavirus disease 2019(COVID-19) is still not ascertained at present. Combined with the previous evidence and therapeutic plan formulated based on clinical first-line therapeutic experience of COVID-19, research progress in drug therapy for COVID-19 was reviewed from the aspect of antiviral drugs such as nucleoside reverse transcriptase inhibitors and nucleoside analogues, as well as convalescent plasma therapy.

    Reference
    Related
Get Citation

李毅, 崔艳慧, 潘频华,等.新型冠状病毒肺炎药物治疗研究进展[J].中国感染控制杂志英文版,2020,19(10):945-950. DOI:10.12138/j. issn.1671-9638.20206411.
LI Yi, CUI Yan-hui, PAN Pin-hua, et al. Research progress in drug therapy for coronavirus disease 2019[J]. Chin J Infect Control, 2020,19(10):945-950. DOI:10.12138/j. issn.1671-9638.20206411.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:April 24,2020
  • Revised:
  • Adopted:
  • Online: October 28,2020
  • Published: